CN102836324A - Decoction for treating schizophrenia - Google Patents

Decoction for treating schizophrenia Download PDF

Info

Publication number
CN102836324A
CN102836324A CN2012103504491A CN201210350449A CN102836324A CN 102836324 A CN102836324 A CN 102836324A CN 2012103504491 A CN2012103504491 A CN 2012103504491A CN 201210350449 A CN201210350449 A CN 201210350449A CN 102836324 A CN102836324 A CN 102836324A
Authority
CN
China
Prior art keywords
parts
radix
decoction
rhizoma
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012103504491A
Other languages
Chinese (zh)
Other versions
CN102836324B (en
Inventor
李龙飞
张焕君
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012103504491A priority Critical patent/CN102836324B/en
Publication of CN102836324A publication Critical patent/CN102836324A/en
Application granted granted Critical
Publication of CN102836324B publication Critical patent/CN102836324B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to decoction for treating schizophrenia. The decoction is prepared from the following materials in parts by weight: 3 parts of liquorice, 2 parts of radix asparagi, 3 parts of glossy privet fruit, 2 parts of costustoot, 5 parts of fructus schisandrae, 2 parts of rhizoma cimicifugae, 4 parts of radix morindae officinalis, 2 parts of cortex eucommiae, 4 parts of nightshade, 3 parts of seville orange flower, 2 parts of white atractylodes rhizome, 6 parts of radix clematidis, 10 parts of gansui root, 2 parts of white paeony root, 8 parts of albizia flower and 10 parts of rhizoma acori graminei. The decoction is convenient to take orally, has obvious effect and is suitable for large-scale clinical popularization.

Description

The schizoid decoction of a kind of treatment
Technical field
The present invention relates to the psychosis prevention field, relate in particular to a kind of decoction of treating schizophrenia.
Background technology
Schizophrenia is a kind of mental sickness that the cause of disease it be unclear that, and a lot of diseases are in person between twenty and fifty, and onset is slow, and the many protracteds course of disease of patient's natural history are and increase the weight of repeatedly or worsen.At present, treat schizophrenia medicine loxapine class commonly used clinically, the not ideal and easy relapse of curative effect, side effect is also very big.
Summary of the invention
The purpose of this invention is to provide a kind of decoction of treating schizophrenia.
In order to realize the object of the invention; The present invention provides a kind of treatment schizoid decoction, and it is to be processed by following materials by weight: 10 parts of 3 parts in Radix Glycyrrhizae, 2 parts of Radix Asparagis, 3 parts of Fructus Ligustri Lucidi, 2 parts of the Radix Aucklandiae, 5 parts of Fructus Schisandrae Chinensis, 2 parts of Rhizoma Cimicifugaes, 4 parts of Radix Morindae Officinaliss, 2 parts of the Cortexs Eucommiae, 4 parts of Herba Solani Nigris, 3 parts of CitrusaurantiumL.Var.amara Engl.s, 2 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Clematidis, 10 parts of Radix Kansuis, 2 parts of the Radix Paeoniae Albas, 8 parts of Flos Albiziaes and Rhizoma Acori Graminei.
The schizoid decoction convenient oral of treatment of the present invention, effect is remarkable, is suitable for large-scale promotion clinically.
The specific embodiment
Further specify the present invention through embodiment below.It should be understood that embodiments of the invention are to be used to explain the present invention rather than limitation of the present invention.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the present invention and requires the scope protected.Except as otherwise noted, otherwise the percent among the present invention is percetage by weight.
Embodiment 1
Take by weighing Radix Glycyrrhizae 30 grams, Radix Asparagi 20 grams, Fructus Ligustri Lucidi 30 grams, the Radix Aucklandiae 20 grams, Fructus Schisandrae Chinensis 50 grams, Rhizoma Cimicifugae 20 grams, Radix Morindae Officinalis 40 grams, the Cortex Eucommiae 20 grams, Herba Solani Nigri 40 grams, CitrusaurantiumL.Var.amara Engl. 30 grams, the Rhizoma Atractylodis Macrocephalae 20 grams, Radix Clematidis 60 grams, Radix Kansui 100 grams, the Radix Paeoniae Alba 20 grams, Flos Albiziae 80 grams and Rhizoma Acori Graminei 100 grams; Add 1000 milliliters of entry; Depressed reflux 3 hours at 1 standard atmosphere; Be cooled to 25 ℃, filter, collect filtrating and promptly get decoction of the present invention.
Experimental example
Schizophrenic's 65 examples that selection is made a definite diagnosis are organized as treatment; Wherein the patient all meets " Chinese mental sickness classification and diagnostic criteria (third edition) " schizoid diagnostic criteria; The positive and scale for the assessment of negative symptoms (PANSS) scoring be not less than 60 minutes (psychiatric department branch of Chinese Medical Association. classification of Chinese mental disorder and diagnostic criteria (third edition) [M]. Jinan: Shandong science tech publishing house, 2002:75.).Get rid of patient, get rid of ethanol or drug dependence patient, disturbance of intelligence person and just using other antischizophrinic things person with physical diseases such as severe cardiac, liver and kidneys.Wherein male 39 examples, women 26 examples; 19~59 years old age, average 32.1 years old.
The preparation decoction is treated among the use embodiment 1, three times on the one, each 50 milliliters, treats for 10 weeks continuously.
Curative effect determinate standard
Adopt the positive and scale for the assessment of negative symptoms (PANSS), untoward reaction scale (TESS) evaluation curative effect and untoward reaction, before treatment, reach the treatment back and respectively evaluated 1 time in 2,4,8,10 weeks.Subtracting the branch rate with PANSS is healing greater than 75%; Subtract the branch rate and be marked improvement greater than 50%; Subtract the branch rate and be progress greater than 25%; Subtract the branch rate less than 25% for failing to respond to any medical treatment.Healing, marked improvement, progressive always adding up to effectively.
The result
Therapeutic outcome sees the following form.
PANSS scoring (n=65,
Figure BSA00000780243000031
) before and after table 1 patient treatment
Table 2 patient clinical efficacy [example (%)]
Figure BSA00000780243000033
TESS scoring
Figure BSA00000780243000034
behind table 3 patient treatment
Figure BSA00000780243000035
In therapeutic process, the less appearance of adverse effect.

Claims (1)

1. treat schizoid decoction for one kind; It is characterized in that it is to be processed by following materials by weight: 10 parts of 3 parts in Radix Glycyrrhizae, 2 parts of Radix Asparagis, 3 parts of Fructus Ligustri Lucidi, 2 parts of the Radix Aucklandiae, 5 parts of Fructus Schisandrae Chinensis, 2 parts of Rhizoma Cimicifugaes, 4 parts of Radix Morindae Officinaliss, 2 parts of the Cortexs Eucommiae, 4 parts of Herba Solani Nigris, 3 parts of CitrusaurantiumL.Var.amara Engl.s, 2 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts of Radix Clematidis, 10 parts of Radix Kansuis, 2 parts of the Radix Paeoniae Albas, 8 parts of Flos Albiziaes and Rhizoma Acori Graminei.
CN2012103504491A 2012-09-20 2012-09-20 Decoction for treating schizophrenia Expired - Fee Related CN102836324B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012103504491A CN102836324B (en) 2012-09-20 2012-09-20 Decoction for treating schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012103504491A CN102836324B (en) 2012-09-20 2012-09-20 Decoction for treating schizophrenia

Publications (2)

Publication Number Publication Date
CN102836324A true CN102836324A (en) 2012-12-26
CN102836324B CN102836324B (en) 2013-11-13

Family

ID=47364227

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012103504491A Expired - Fee Related CN102836324B (en) 2012-09-20 2012-09-20 Decoction for treating schizophrenia

Country Status (1)

Country Link
CN (1) CN102836324B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10383910B2 (en) 2016-04-27 2019-08-20 King Abdulaziz University Methods of increasing fertility of a male subject with costus speciosus extract

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101579511A (en) * 2009-07-02 2009-11-18 陈雪梅 Drug combination used for treating schizophrenia
CN102078559A (en) * 2009-12-01 2011-06-01 王小华 Chinese medicinal composition with functions of tonifying kidney and strengthening brain
CN102319406A (en) * 2011-10-10 2012-01-18 张运林 Medicament for treating tristimania
CN102657819A (en) * 2012-05-16 2012-09-12 高新华 Drug combination for treating dysthymic disorder

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101579511A (en) * 2009-07-02 2009-11-18 陈雪梅 Drug combination used for treating schizophrenia
CN102078559A (en) * 2009-12-01 2011-06-01 王小华 Chinese medicinal composition with functions of tonifying kidney and strengthening brain
CN102319406A (en) * 2011-10-10 2012-01-18 张运林 Medicament for treating tristimania
CN102657819A (en) * 2012-05-16 2012-09-12 高新华 Drug combination for treating dysthymic disorder

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10383910B2 (en) 2016-04-27 2019-08-20 King Abdulaziz University Methods of increasing fertility of a male subject with costus speciosus extract

Also Published As

Publication number Publication date
CN102836324B (en) 2013-11-13

Similar Documents

Publication Publication Date Title
CN101530599B (en) A pharmaceutical composition for treating mental depression
CN102302751A (en) Chinese medicine for treating migraine
CN102698233A (en) Traditional Chinese medicine mixture for treating cold-fluid heat type child capillary bronchitis and preparation method of same
CN102430071B (en) Medicament for treating herpes zoster
CN102743645B (en) Chinese medicinal preparation for treating premature ejaculation
CN102836324B (en) Decoction for treating schizophrenia
CN102488756A (en) Medicament for treating dry eye syndrome
CN102552512A (en) Traditional Chinese medicine used for treating hepatitis B
CN101411770B (en) Medicament for treating blood stasis accumulation type multiple sclerosis symptoms
CN104306897A (en) Traditional Chinese medicine composition for treating climacterium syndrome
CN101548993B (en) Application of Japanese climbing fern spore in preparing lead excretion medicines or health products
CN101194982B (en) Antidepressive Chinese medicine composition and method of preparing the same
CN102302719B (en) Medicament for treating tumor
CN102988708B (en) Traditional Chinese medicine for treating fever
CN102657786B (en) Drinking potion for treating mania
CN103550606A (en) Medicament for treating hypersensitive dentin
CN102370863B (en) Traditional Chinese medicine for treating bronchial asthma
CN102772763B (en) Traditional Chinese medicinal composition for resisting tumor metastasis and method for preparing traditional Chinese medicinal composition
CN101444607A (en) Method for preparing Chinese herbs to cure liver cancer
CN101569726A (en) Chinese medicament for treating fracture contusion
CN103041346A (en) Decoction for treating dysmenorrhea
CN104800599A (en) Traditional Chinese medicinal composition for treating deficiency of kidney-yin
CN102961530A (en) Pure traditional Chinese medicine composition for enhancing immunity and preparation method thereof
CN104274673B (en) A kind of Chinese medicine composition for treating oligospermatism
CN102552581B (en) Medicament for treating insomnia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131113

Termination date: 20150920

EXPY Termination of patent right or utility model